Oligodendrogliomas Recruiting Phase 1 Trials for Doxorubicin (DB00997)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02372409Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain TumorsTreatment